Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats

European Journal of Pharmacology

Volumn 590, Issue 1-3, 2008, Pages 310-316

  Kong, Zi Qing ^a,b   Fu, Cai Yun ^a,b   Chen, Qiang ^a   Wang, Rui ^a,b  

^a North West Normal University   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Adrenal medulla; Cardiovascular; Human hemokinin 1; Human hemokinin 1(4 11); SR140333; Sympathetic ganglia

Indexed keywords

ATROPINE; CATECHOLAMINE; ENDOTHELIUM DERIVED RELAXING FACTOR; HEMOKININ 1 [4-11]; HUMAN HEMOKININ 1; N (ALPHA ETHYLBENZYL) 3 METHYL 2 PHENYL 4 QUINOLINECARBOXAMIDE; N(G) NITROARGININE METHYL ESTER; NOLPITANTIUM; PHENTOLAMINE; PROPRANOLOL; RESERPINE; SAREDUTANT; TACHYKININ DERIVATIVE; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ADRENALECTOMY; ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DOSE RESPONSE; DRUG ANTAGONISM; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC GANGLION; TACHYCARDIA; VAGUS REFLEX;

ANESTHESIA; ANIMALS; ATROPINE; BENZAMIDES; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HUMANS; MALE; NG-NITROARGININE METHYL ESTER; PEPTIDE FRAGMENTS; PHENTOLAMINE; PIPERIDINES; PROPRANOLOL; QUINOLINES; QUINUCLIDINES; RATS; RATS, WISTAR; TACHYKININS;

EID: 48149100246     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.05.049     Document Type: Article

References (36)

1. Adveniernier C., Rouissi N., Nguyen Q.T., Emonds-Alt X., Breliere J.C., Neliat G., Naline E., and Regoli D. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem. Biophys. Res. Commun. 184 (1992) 1418-1424
2. Bellucci F., Carini F., Catalani C., Cucchi P., Lecci A., Meini S., Patacchini R., Quartara L., Ricci R., Tramontana M., Giuliani S., and Maggi C.A. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br. J. Pharmacol. 135 (2002) 266-274
3. Berger A., and Paige C.J. Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study. J. Neuroimmunol. 164 (2005) 48-56
4. Camarda V., Rizzi A., Calo G., Guerrini R.S., and Regoli D. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci. 71 (2002) 363-370
5. Chahl L.A., and Walker S.B. Responses of the rat cardiovascular system to substance P, neurotensin and bombesin. Life Sci. 29 (1981) 2009-2015
6. Champion H.C., Zadina J.E., Kastin A.J., and Kadowitz P.J. Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse. Peptides 19 (1998) 925-929
7. Couture R., Laneuville O., Guimond C., Drapeau G., and Regoli D. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Arch. Pharm. 340 (1989) 547-557
8. Delbro D. Substance P induced tachycardia in the anaesthetized rat. Acta Physiol. Scand. 130 (1987) 41-45
9. Devillier P., Renoux X., Giroud J.P., and Regoli D. Peptides and histamine release from rat peritoneal mast cells. Eur. J. Pharmacol. 117 (1985) 89-96
10. Duffy R.A., Hedrick J.A., Randolph G., Morgan C.A., Cohen-Williams M.E., Vassileva G., Lachowicz J.E., Laverty M., Maguire M., Shan L.-S., and Gustafson E. Centrally administered hemokinin-1 (HK-1), a neurokinin tachykinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology 45 (2003) 242-250
11. Emonds-Alt X., Doutremepuich J.D., Heaulme M., Neliat G., Santucci V., Steinberg R., Vilain P., Bichon D., Ducoux J.P., Proietto V., Van Broeck D., Soubrie P., Le Fur G., and Breliere J.C. In vitro and in vivo biological activities of SR 140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur. J. Pharmacol. 250 (1993) 403-413
12. Fiscus R.R., Gross D.R., Hao H., Wang X., Arden W.A., Maley R.H., and Salley R.K. N omega-nitro-l-arginine blocks the second phase but not the first phase of the endothelium-dependent relaxations induced by substance P in isolated rings of pig carotid artery. J. Cardiovasc. Pharmacol. 20 (1992) S105-S108
13. Fu C.Y., Kong Z.Q., Long Y., Chen Q., and Wang R. Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: systemic study in anesthetized rats. Eur. J. Pharmacol. 572 (2007) 175-181
14. Fu, C.Y., Zhao, Y.L., Dong, L., Chen, Q., Ni, J.M., Wang, R., in press. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain. Behav. Immun.
15. Gerard N.P., Eddy R.L., Shows T.B., and Gerard C. The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues. J. Biol. Chem. 265 (1990) 20455-20462
16. Giardina G.A.M., Henry M., Sarau H.M., Farina C., Medhurst A.D., Grugni M., Foley J.J., Raveglia L.F., Schmidt D.B., Rigolio R., Vassallo M., Vecchietti V., and Hay D.W.P. 2-phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. J. Med. Chem. 39 (1996) 2281-2284
17. Hancock J.C., and Lindsay G.W. Pressor and tachycardic responses to intravenous substance P in anesthetized rats. Peptides 16 (1995) 1439-1445
18. Kurtz M.M., Wang R., Clements M.K., Cascieri M.A., Austin C.P., Cunningham B.R., Gary G.C., and Liu Q.Y. Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 296 (2002) 205-212
19. Kwok E.H., and Dun N.J. Endomorphins decrease heart rate and blood pressure possibly by activating vagal afferents in anesthetized rats. Brain Res. 803 (1998) 204-207
20. Longmore J., Hill R.G., and Hargreaves R.J. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs. Can. J. Physiol. Pharm. 75 (1997) 612-621
21. Maggio J.E. Tachykinins. Annu. Rev. Neurosci. 11 (1988) 13-28
22. Morteau O., Lu B., Gerard C., and Gerard N.P. Hemokinin 1 is a full agonist at the substance P receptor. Nat. Immunol. 2 (2001) 1088
23. Nelson D.A., and Bost K.L. Non-neuronal mammalian tachykinin expression. Front. Biosci. 9 (2004) 2166-2176
24. Page N.M. Hemokinins and endokinins. Cell. Mol. Life Sci. 61 (2004) 1652-1663
25. Page N.M. New challenges in the study of the mammalian tachykinins. Peptides 26 (2005) 1356-1368
26. Page N.M., Bell N.J., Gardiner S.M., Manyonda I.T., Brayley K.J., Strange P.G., and Lowry P.J. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6245-6250
27. Patacchini R., Lecci A., Holzer P., and Maggi C.A. Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol. Sci. 25 (2004) 1-3
28. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci. 74 (2004) 1445-1463
29. Pennefather J.N., Patak E., Ziccone S., Lilley A., Pinto F.M., Page N.M., Story M.E., Grover S., and Candenas M.L. Regulation of the stimulant actions of neurokinin A and human hemokinin-1 on the human uterus: a comparison with histamine. Biol. Reprod. 75 (2006) 334-341
30. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharmacol. Rev. 54 (2002) 285-322
31. Takahashi K., Tanaka A., Hara M., and Nakanishi S. The primary structure and gene organization of human substance P and neuromedin K receptors. Eur. J. Biochem. 204 (1992) 1025-1033
32. Takeda Y., Chou K.B., Takeda J., Sachais B.S., and Krause J.E. Molecular cloning, structural organization and functional expression of the human substance P receptor. Biochem. Biophys. Res. 179 (1991) 1232-1240
33. Wang C.L., Yu Y., Lai L.H., Cui Y., Wang X., and Wang R. Cardiovascular responses to intrathecal administration of endomorphins in anesthetized rats. Peptides 28 (2007) 871-877
34. Yoshioka D., Takebuchi F., Nishimori T., Naono R., Ikeda T., and Nakayama T. Intrathecal administration of the common carboxyl-terminal decapeptide in endokinin A and endokinin B evokes scratching behavior and thermal hyperalgesia in the rat. Neurosci. Lett. 410 (2006) 193-197
35. Yu Y., Wang C.L., Cui Y., Fan Y.Z., Liu J., Shao X., Liu H.M., and Wang R. C-terminal amide to alcohol conversion changes the cardiovascular effects of endomorphins in anesthetized rats. Peptides 27 (2006) 136-143
36. Zhang Y., Lu L., Frulonger C., Wu G.E., and Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1 (2000) 392-397